| scholarly article | Q13442814 |
| P2093 | author name string | ELLIS BC | |
| STRANSKY A | |||
| P304 | page(s) | 477-488 | |
| P577 | publication date | 1961-09-01 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | A quick and accurate method for the determination of fibronogen in plasma | |
| P478 | volume | 58 |
| Q41262553 | A batch method for estimating thrombin clottable fibrinogen |
| Q41827596 | A comparison of the effect of frusemide and bumetanide on the diuretic response and fibrinolytic mechanism in man. |
| Q30441062 | A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion |
| Q70909998 | Acute promyelocytic leukemia |
| Q33839147 | Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays |
| Q54416238 | Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. |
| Q34783092 | Blood viscosity after splenectomy |
| Q41248297 | Cerebral involvement with disseminated intravascular coagulation in intestinal disease |
| Q36709432 | Clotting factor VIII (FVIII) and thrombin generation in camel plasma: A comparative study with humans |
| Q66992938 | Coagulation abnormalities in diabetic coma before and 24 hours after treatment |
| Q71605380 | Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis |
| Q39645453 | Comparison of an immunochemical assay for plasma fibrinogen and a turbidimetric thrombin clotting technique to discriminate hyperlipidaemic patients from healthy controls |
| Q34283513 | Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin |
| Q70336462 | Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood |
| Q45887538 | Double cryoprecipitated factor VIII concentrate from heparinised plasma and its heat treatment |
| Q37045458 | Dysfibrinogenemia associated with liver disease |
| Q67595513 | Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl) |
| Q33378294 | Effect of a selective PAF antagonist SM-10661 ((±)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC) |
| Q36249841 | Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro |
| Q71790916 | Effects of Poisoning on Serum Enzyme Activities, Coagulation, and Fibrinolysis |
| Q41227253 | Evaluation of a rapid method for the determination of plasma fibrinogen |
| Q41238758 | Excess intravascular coagulation complicating low cardiac output |
| Q33468629 | Experience with disseminated intravascular coagulation in a children's hospital |
| Q42942061 | Fibrin(ogen) mediates acute inflammatory responses to biomaterials |
| Q36062704 | Fibrin-fibrinogen degradation products in sera of normal infants and children |
| Q34462314 | Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism |
| Q35180922 | Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes |
| Q36999425 | Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation |
| Q67413835 | Hemostatic alterations in inflammatory bowel disease: response to therapy |
| Q78081224 | Hypercoagulable states in patients with retinal venous occlusion |
| Q41245378 | Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis |
| Q36647123 | Intravascular coagulation and E. coli septicaemia |
| Q35490349 | Investigation of factors which might indicate susceptibility to particulate air pollution |
| Q34463206 | Measurement of fibrinopeptide A in human blood |
| Q69543859 | Mechanisms of Thrombocytopenia in Malignant Tertian Malaria |
| Q41251402 | Modification of plasma fibrinogen method |
| Q55065905 | Outbreake of Marburg virus disease in Johannesburg. |
| Q37183198 | Platelet and coagulation factors in proliferative diabetic retinopathy |
| Q73897052 | Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders |
| Q47421749 | RELATION BETWEEN RATE OF CATABOLISM, PLASMA CONCENTRATION AND POOL SIZE OF FIBRINOGEN. |
| Q37017511 | Sequence of Fibrinogen Proteolysis and Platelet Release after Intrauterine Infusion of Hypertonic Saline |
| Q70098481 | Serum fibrin degradation products throughout normal pregnancy |
| Q33472971 | Subendocardial infarction and thrombocytopenia |
| Q36171684 | TURNOVER OF 131-I-LABELLED FIBRINOGEN IN FEVER |
| Q37401331 | The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin. |
| Q42540465 | The effect of assembly and transit stressors on plasma fibrinogen concentration of beef calves |
| Q42618528 | The effect of indomethacin on the biochemical response to fracture stress in rats |
| Q41252037 | The euglobulin lysis time test: An ineffectual monitor of the therapeutic inhibition of fibrinolysis |
| Q35905116 | The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity |
| Q53761692 | The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy. |
| Q83022107 | Tissue factor pathway inhibitor in childhood nephrotic syndrome |
| Q67352678 | Treatment of Goodpasture's disease by plasma exchange and immunosuppression |
| Q34353267 | Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects. |
| Q49213842 | Use of epsilon aminocaproic acid |
| Q39659684 | Viscosimetric effect of fibrinogen |
| Q72762767 | [Determination of fibrinolysis time with the lysograph. Investigations on 57 healthy volunteers] |
Search more.